Abbott Laboratories’ said its experimental dissolvable heart stent has received approval in Europe, a key milestone in the development of the next-generation heart device for patients in the U.S. and around the world.
The North Chicago-based drug and medical device giant said it is the first-ever government regulatory approval of an absorbable stent. Get the full story »
